Upgrade to SI Premium - Free Trial

Regeneron Pharma (REGN) PT Raised to $352 at BMO Capital

November 5, 2019 3:43 PM
BMO Capital analyst Matthew Luchini raised the price target on Regeneron Pharma (NASDAQ: REGN) to $352.00 (from $344.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change

Next Articles